| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
CEO | President &CEO | See Remarks
2 companies
Shah Gaurav is a CEO at RCKTW with holdings across 2 companies. Recent SEC Form 4 filings include 1 buy and 8 sells.
Estimated insider holdings value: $2.7M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 16, 2024 | RCKT Rocket Pharmaceuticals, Inc. | CEO | Sale+OE | 9,790 | $23.35 | $228,596.50 | -1.3% | -22.0% | -72.2% | |
| Feb 16, 2024 | RCKT Rocket Pharmaceuticals, Inc. | CEO | Sell | 20,272 | $29.84 | $604,875.94 | -3.5% | -22.0% | -65.1% | |
| Aug 17, 2023 | RCKT Rocket Pharmaceuticals, Inc. | CEO | Sell | 4,767 | $15.47 | $73,750.26 | -0.9% | +42.5% | +23.7% | |
| May 17, 2023 | RCKT Rocket Pharmaceuticals, Inc. | CEO | Sell | 4,122 | $21.38 | $88,107.75 | -0.8% | -24.7% | +8.5% | |
| Feb 17, 2023 | RCKT Rocket Pharmaceuticals, Inc. | CEO | Sell | 12,194 | $19.06 | $232,417.64 | -2.2% | +9.2% | +54.0% | |
| Feb 7, 2022 | RCKT Rocket Pharmaceuticals, Inc. | CEO | Buy | 22,000 | $17.34 | $381,513.00 | +4.4% | -52.7% | +20.2% | |
| Mar 5, 2019 | RCKT Rocket Pharmaceuticals, Inc. | See Remarks | Sell | 74,900 | $17.17 | $1,286,272.00 | -3.4% | - | - |